| October 31, 2002 |
October 31, 2002
Cerus Corporation Receives Commitment for $50 Million Financing From Baxter
|
| October 31, 2002 |
October 31, 2002
Cerus Corporation Announces Third Quarter Results
|
| October 24, 2002 |
October 24, 2002
Webcast Alert: Cerus Corporation Announces Third Quarter Financial Results Conference Call
|
| October 23, 2002 |
October 23, 2002
Cerus Corporation Appoints Elizabeth M. Tillson, Ph.D. as Vice President, Regulatory Affairs and Quality
|
| October 16, 2002 |
October 16, 2002
Baxter and Cerus Announce Final European Regulatory Clearance for the First Pathogen Inactivation System for Platelets
|
| September 26, 2002 |
September 26, 2002
Cerus Corporation Receives $6.5 Million Award in Expanded Collaboration With the U.S. Armed Forces
|
| July 31, 2002 |
July 31, 2002
Cerus Corporation Announces Second Quarter Results
|
| July 17, 2002 |
July 17, 2002
Cerus Corporation Invites You to Join a Webcast of Its Second Quarter Conference Call.
|
| July 11, 2002 |
July 11, 2002
Cerus Corporation Receives $5 Million Milestone Payment From Baxter Healthcare Corporation
|
| June 26, 2002 |
June 26, 2002
Cerus Corporation Expands U.S. Patent Coverage for Pathogen Inactivation in Blood
|
| June 4, 2002 |
June 4, 2002
Cerus Invites You to a Company Update via the Web
|
| June 4, 2002 |
June 4, 2002
Cerus and Baxter's INTERCEPT Disposable Set for Platelets Receives European Regulatory Approval.
|
| April 25, 2002 |
April 25, 2002
Cerus Corporation Announces First Quarter Results
|
| April 12, 2002 |
April 12, 2002
Cerus Corporation Invites You to Join a Webcast of its First Quarter Conference Call
|
| April 11, 2002 |
April 11, 2002
Cerus Corporation Names William R. Rohn to Board of Directors
|
| February 21, 2002 |
February 21, 2002
Cerus and Baxter Receive FDA Concurrence to Begin Phase III INTERCEPT Red Blood Cell Trial in Chronic Indications
|
| January 24, 2002 |
January 24, 2002
Cerus Corporation Announces Fourth Quarter and Year End 2001 Results
|
| January 14, 2002 |
January 14, 2002
Cerus Corporation Invites You to Join a Webcast of Its Fourth Quarter Conference Call
|
| January 9, 2002 |
January 9, 2002
Cerus and Baxter Initiate Clinical Site in Pivotal Phase III Trial for INTERCEPT Red Blood Cell System
|